ABEONA THERAPEUTICS INC. Accumulated Other Comprehensive Income
ABEONA THERAPEUTICS INC. (ABEO) had Accumulated Other Comprehensive Income of -$79.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$79.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$21.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $138.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $10.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$79.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$21.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $138.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $10.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$45.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$67.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $8.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | -$84.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$134.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$184.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$66.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$99.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$95.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$65.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$129.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | -$44.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$34.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$30.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$27.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | -$9.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$1.00K 10-Q · filed 2021-07-28 |
| 2021-03-31 | $3.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$10.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $17.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $133.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $386.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |